Form 4 for ALAB Astera Labs, Inc.
Accepted 2025-08-20 00:00:00 ET · period of report 2025-08-18 · accession 0001736297-25-000114 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-20 | 2025-08-19 | ALAB | Tate Michael Truett | CFO | G - Gift | $0.00 | -55.8K | 203.7K | -21% | $0 | |
| M | 2025-08-20 | 2025-08-18 | ALAB | Tate Michael Truett | CFO | S - Sale | $183.51 | -18.9K | 268.7K | -7% | -$3.46M |
| I | 2025-08-20 | 2025-08-19 | ALAB | Tate Michael Truett | CFO | G - Gift | $0.00 | +55.8K | 457.3K | +14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-19 | G | D | 55,785 | $0.00 | 203,727 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-18 | S | D | 9,193 | $183.17 | 259,512 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $183.4400 to $182.8700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2025-08-19 | G | A | 55,785 | $0.00 | 457,281 | I | — | — | |
| 4 | Common | Common Stock | 2025-08-18 | S | D | 9,668 | $183.83 | 268,705 | D By Tate Trust | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $184.4400 to $183.4500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F5) These shares are owned directly by the Tate Trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |